FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Fresenius Kabi Heparin Sodium Injection Recall

Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For I…

Fresenius Kabi USA, LLC · Grand Island, NY

Risk level
Class II
Reported by FDA
Mar 12, 2014
Recall ID
D-1148-2014
Check your lot numberHow we source this data

Summary

Fresenius Kabi recalled Heparin Sodium Injection starting Jan 22, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1148-2014 on Mar 12, 2014. Reason: Subpotent; 18 month time point. Status: Terminated.

Why it was recalled

Subpotent; 18 month time point

Product description

Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For IV or SC use, Multi-Dose Vial, Rx only, NDC 63323-540-11, 25 vials in tray, each boxed vial individually labeled as: Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For IV or SC use, Multi-Dose Vial, Rx only, NDC 63323-540-11.

Lot numbers, UPCs & expiration codes

Lot Number: 6004137, Expiration date: 06/2014

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1148-2014
Classification
Class II
Status
Terminated
Recall initiated
Jan 22, 2014
FDA report date
Mar 12, 2014
Quantity
161,650 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Fresenius Kabi USA, LLC

Original FDA data

Every field from FDA enforcement report D-1148-2014, exactly as published.

Show all FDA fields
City
Grand Island
State
NY
Status
Terminated
Country
United States
Event ID
67330
Address
3159 Staley Rd
Code information
Lot Number: 6004137, Expiration date: 06/2014
Postal code
14072-2028
Report date
Mar 12, 2014
Product type
Drugs
Recall number
D-1148-2014
Classification
Class II
Recalling firm
Fresenius Kabi USA, LLC
Product quantity
161,650 vials
Termination date
May 24, 2016
Reason for recall
Subpotent; 18 month time point
Voluntary / mandated
Voluntary: Firm initiated
Product description
Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For IV or SC use, Multi-Dose Vial, Rx only, NDC 63323-540-11, 25 vials in tray, each boxed vial individually labeled as: Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For IV or SC use, Multi-Dose Vial, Rx only, NDC 63323-540-11.
Distribution pattern
Nationwide
Recall initiation date
Jan 22, 2014
Initial firm notification
Letter
Center classification date
Mar 5, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1148-2014, published Mar 12, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls